2/25/2019 Indian Pharmaceuticals Industry Analysis: A Sectoral Presentation

INFOGRAPHIC (HTTPS://WWW.IBEF.ORG/INDUSTRY/PHARMACEUTICAL-
INDIA/INFOGRAPHIC)
REPORTS (HTTPS://WWW.IBEF.ORG/INDUSTRY/INDIAN-PHARMACEUTICALS-
INDUSTRY-ANALYSIS-PRESENTATION)

Last Updated: January, 2019

Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent
of generic demand in the US and 25 per cent of all medicine in UK. India contributes the second largest share of
pharmaceutical and biotech workforce in the world. The pharmaceutical sector in India was valued at US$ 33 billion
in 2017. India’s domestic pharmaceutical market turnover reached Rs 129,015 crore (US$ 18.12 billion) in 2018,
growing 9.4 per cent year-on-year (in Rs) from Rs 116,389 crore (US$ 17.87 billion) in 2017.

With 71 per cent market share, generic drugs form the largest segment of the Indian pharmaceutical sector.
Domestic API consumption is expected to reach US$ 18.8 billion by FY22. The country accounts for the second
largest number of Abbreviated New Drug Applications (ANDAs) and is the world’s leader in Drug Master Files
(DMFs) applications with the US Indian Drugs & Pharmaceuticals sector has received cumulative FDI worth US$
15.83 billion between April 2000 and June 2018.

Indian drugs are exported to more than 200 countries in the world, with the US as the key market. Generic drugs
account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic
medicines globally and expected to expand even further in coming years. India’s pharmaceutical exports stood at
US$ 17.27 billion in FY18 and US$ 12.29 billion in FY19 (up to November 2018). In 2018-19, these exports are
expected to cross US$ 19 billion. 31 per cent of these exports from India went to the US.

The Government of India plans to set up a US$ 640 million venture capital fund to boost drug discovery and
strengthen pharmaceutical infrastructure. The ‘Pharma Vision 2020’ by the government’s Department of
Pharmaceuticals aims to make India a major hub for end-to-end drug discovery.

Indian Pharmaceuticals Industry Report (January, 2019)

(https://www.ibef.org/download/pharmaceuticals-jan-2019.pdf) (Size: 1.17 MB )

Indian Pharmaceuticals Industry Report (December, 2018)

(https://www.ibef.org/download/pharmaceuticals-dec-2018.pdf) (Size: 1.16 MB )

Click to access the Pharmaceuticals Industry Archived Report (https://www.ibef.org/archives/industry/indian-

pharmaceuticals-industry-analysis-reports)

IBEF BLOG - INDIA ADDA – PERSPECTIVES ON INDIA 

(HTTPS://WWW.IBEF.ORG/BLOGS) More (https://www.ibef.org/blogs)


Solar energy generation in India: Lighting lives!
(https://www.ibef.org/blogs/solar-energy-generation-in-india-lighting-
lives)
IBEF, Knowledge Centre
The generation of power from solely renewable sources like solar energy is a
prime focus of India’s energy planning. Started in the early 1970s, the process
of crea...

Digital payment industry in India (https://www.ibef.org/blogs/digital-

payment-industry-in-india)
IBEF, Knowledge Centre
From being primarily a cash-obsessed economy, India’s digital payment story
MORE (HTTPS://WWW.IBEF.ORG/INNOVATIONS-FROM-
IDEAS
INDIA.ASPX)

https://www.ibef.org/industry/indian-pharmaceuticals-industry-analysis-presentation 3/5